Return to search

F2G raises $60 mln

F2G Ltd said June 20 that it raised $60 million in financing led by Sectoral Asset Management. Novo A/S, Aisling Capital and Brace Pharma Capital also invested. Existing investors Advent Life Sciences LLP, Novartis Venture Fund, Sunstone Capital and Merifin Capital each participated in the round. F2G is a UK biotech company focused on the discovery and development of novel therapies to treat life threatening invasive fungal infection.

Source: PRNewswire